Research Interest: Our lab is focused on uncovering the involvement of the endocannabinoid system in the pathogenesis of obesity and its metabolic complications, with therapeutic prospects for the development of an effective drug therapy.                                                                                                     

Key Words: Endocannabinoids; Cannabinoid-1 (CB1) receptor; Diet-induced Obesity; Diabetes; Metabolic syndrome; Leptin Resistance; Diabetic Nephropathy; Renal function; Syndromic Obesity; Prader-Willi Syndrome; Non-alcoholic fatty liver disease (NAFLD); Insulin resistance;  Drug design; Nanotechnology; Endocrinology; Pharmacology; Metabolism